-
UPDATE: TEVA To Buy Cephalon for $6.8 billion; Shares Rise In Pre-Market Trading
Monday, May 2, 2011 - 7:50am | 85Shares of Cephalon Inc (NASDAQ: CEPH) and Teva Pharmaceutical Industries (NASDAQ: TEVA) gained in pre-market trading after TEVA agreed to purchase Cephalon for $6.8 billion. Teva's cash offer of $81.50 per share represents a 6% premium over Cephalon closing price on Friday. CEPH shares gained 6....
-
Citi Maintains PT of $29 on Shares of Warner Chilcott Plc
Monday, May 2, 2011 - 7:49am | 35Today, Citi Maintained its Price Target of $29 on shares of Warner Chilcott Plc (WCRX) ahead of earnings later this week. Shares of Warner Chilcott Plc closed at 23.05 Friday.
-
Acura Pharmaceuticals Announces Appointment of Robert Jones as Interim President and CEO (ACUR)
Monday, May 2, 2011 - 7:41am | 78Acura Pharmaceuticals (Nasdaq: ACUR) announced today that Robert Jones, Acura's Senior Vice President and Chief Operating Officer, has been named the Company's interim President and Chief Executive Officer effective immediately. Mr. Jones succeeds Andy Reddick, who passed away on April 28, 2011. Mr...
-
CEOWORLD Top 10 Dividend Stocks- UGI, CFR, JNJ, ACI, AWR, ARTNA, CVX, GWW, NOC, PH
Monday, May 2, 2011 - 7:32am | 1467UGI Corporation (UGI) - UGI is a distributor and marketer of energy products and services. Through subsidiaries, UGI operates natural gas and electric utilities in Pennsylvania, distributes propane both domestically and internationally, manages midstream energy and electric generation assets in...
-
UPDATE: J.P. Morgan Raises PT on Merck & Co. to $44 (MRK)
Monday, May 2, 2011 - 7:21am | 86J.P. Morgan is out with its report today on Merck & Co. (NYSE: MRK), raising its PT from $42 to $44. In a note to clients, J.P. Morgan writes, "We are increasing our MRK sales and EPS estimates following strong 1Q/11 results. Our new estimates are toward the high end of the company's 2011...
-
Citi Updates FY Estimates On Merck After Reporting Solid Earnings
Monday, May 2, 2011 - 7:14am | 181Citi raised its 2011E EPS from $3.68 to $3.74 vs. the Street's $3.69 & MRK's $3.66-$3.76 range on Merck (NYSE: MRK). The new estimates reflect the 1Q11 beat, partially offset by a higher tax rate & the lost profit from the JNJ settlement on Remicade/Simponi. Citi increased ‘11E-‘14E sales...
-
Teva Acquires Cephalon for $81.50 (TEVA, CEPH)
Monday, May 2, 2011 - 7:07am | 512Teva Pharmaceutical Industries (NASDAQ: TEVA) and Cephalon (NASDAQ: CEPH) today announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value...
-
Cephalon Acquired by Teva for $81.50/Share Cash (CEPH, TEVA)
Monday, May 2, 2011 - 7:05am | 27Cephalon (NASDAQ: CEPH) Acquired by Teva (NASDAQ: TEVA) for $81.50/Share Cash.
-
JP Morgan Raises PT On Merck & Company To $44
Monday, May 2, 2011 - 6:04am | 27JP Morgan has raised the price target on Merck & Company (NYSE: MRK) from $42 to $44 and maintains its Overweight rating.
-
CEOWORLD DAILY BUSINESS AND TECH ROUNDUP- SNE, WMG, DD, GOOG, PFE, AAPL, TWC, TSU, TTC, TWI, T, VZ, JNJ, KFT, INTC
Monday, May 2, 2011 - 5:48am | 1308Sony Corp. (NYSE: SNE) apologized for the breach of its PlayStation Network and Qriocity services, and said it aims to resume the online gaming center by the end of the month after upgrading security. Chiba Bank Ltd. (8331 JT), a regional lender, advanced 6.1 percent to 506 yen. The company said...
-
Piper Jaffray Raises PT On Valeant Pharmaceuticals To $62
Monday, May 2, 2011 - 5:48am | 27Piper Jaffray has raised the price target on Valeant Pharmaceuticals (NYSE: VRX) from $46 to $62 and maintains its Overweight rating.
-
TOP 15 Stocks To Watch this week- AAPL, BRK-A, BRK-B, BJ, C, F, GM, GPRO, IP, KND, N, NRTLQ, ONTY, SPPI, YRCW
Monday, May 2, 2011 - 4:48am | 2069Ford (NYSE:F)- Ford revenue increased 17% from last year to $33.1 billion and reduced its debt by $2.5 billion. The result showed an increase of $466 million over the first quarter of 2010, and is the best first quarter earnings since 1998. Competitors- General Motors Company (GM), Toyota Motor...
-
CEOWORLD Top 5 Analyst Calls of the Week- DNDN, INSP, MCP, SIRI, VICL
Monday, May 2, 2011 - 3:32am | 1198Dendreon Corporation (NASDAQ: DNDN)- Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. The Company's product portfolio includes active cellular...
-
Stocks Going Ex Dividend the Second Week of May
Saturday, April 30, 2011 - 10:23pm | 750Here is our latest update on the stock trading technique called 'Buying Dividends'. This is the process of buying stocks before the ex dividend date and selling the stock shortly after the ex date at about the same price, yet still being entitled to the dividend. This technique generally works only...
-
Royal Put(z) Not to Be Confused with Married Put(z) 04-29-2011
Friday, April 29, 2011 - 6:35pm | 1067Cusick's Corner Some of you might have caught the subject line Married Put(z), this should not be confused with a Royal Put(z). That's enough of the Royals and wedding humor. At this stage the market it is getting a little harder to play the upside, at least buying outright stock with the market...